Inhalable Drugs Market Size, Share, Future Prospects and Forecast 2020-2026

The global inhalable drug market is anticipated to grow at a CAGR of 3.7% during the forecast period (2020-2026). The rising geriatric population that is more prone to respiratory diseases, augmentation in the predominance of respiratory and non-respiratory diseases, along with the rapidly changing lifestyles of the people creates demand for inhalable drugs and hence drives the growth of the market. The trend of smoking, drinking alcohol, and ill eating activity are increasing among the people which is a major risk for the development of various pulmonary diseases. As per the COPD Foundation of the US, the top three causes of COPD are environmental factors, smoking, and genetic factor. COPD is mostly occurred in people of age above 40 and having a history of smoking.

Request a free sample of our report on Inhalable Drugs Market: https://www.omrglobal.com/request-sample/inhalable-drugs-market

Non-respiratory diseases such as diabetes, Parkinson’s diseases, among many others are also becoming increasingly prevalent among the geriatric population. Owing to this, manufacturers are focused on the development of inhalable drugs for adult people as it is hard to swallow for them. For instance, in December 2018, the US FDA approved the INBRIJA drug, manufactured by Acorda Therapeutics as an inhalable prescription medicine for adults suffering from Parkinson’s disease. Thus, such aforementioned factors are likely to positively influence the growth of the market over the forecast period.

A full report of Inhalable Drugs Market Is available at https://www.omrglobal.com/industry-reports/inhalable-drugs-market

Global Inhalable Drugs Market Segmentation
By Applications
• Respiratory Diseases
• Non-Respiratory Diseases

By Route of Administration
• Nasal
• Mouth

Regional Analysis
• North America
o United States
o Canada

• Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe

• Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific

• Rest of the World

Company Profiles
• AptarGroup, Inc.
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson Services Inc.
• Medisol Lifescience Pvt. Ltd.
• Merck & Co., Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/inhalable-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.